Like all other endothelial cells, glomerular endothelial cells form the interface between blood and tissue compartments, and function to regulate vasomotor tone, hemostasis, and trafficking of leukocytes. But unlike endothelium in most other capillary beds, the normal glomerular endothelium is extraordinarily attenuated, being only ∼ 50 to 150 nm high around the circumference of the capillary loops [1] . Glomerular endothelium also is densely perforated by transcellular fenestrae, which constitute 30% to 50% of their surface area. The density and size of glomerular endothelial cell fenestrae account, at least in part, for the high permeability of the glomerular capillary wall to water and small solutes [2] , and loss of fenestrae leads to a reduction in the glomerular filtration rate (GFR) in disorders like preeclampsia.
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ORIGIN OF THE GLOMERULAR ENDOTHELIUM
Vascularization of the developing kidney occurs largely through in situ vasculogenesis. Individual angioblasts bearing vascular endothelial growth factor receptor 2 (VEGFR-2) (Flk-1) are found in mouse metanephric mesenchyme on embryonic day (E) 12, well before any organized blood vessels are observed [3] . Unvascularized metanephric blastema does not form glomerular capillaries in vitro even under conditions that induce hypoxiainducible factor (HIF)-driven VEGF-A expression [4, 5] . However, when E12 metanephroi are implanted under the renal capsule of mature kidneys, glomerular vascularization occurs from cells intrinsic to the implanted metanephric blastema, indicating that in situ vasculogenesis results in glomerular vascularization [3] . Neutralizing antibodies to both, VEGF-A [6] and transforming growth factor-b (TGF-b1) [7] markedly inhibit angioblast migration into the vascular cleft of nascent glomeruli of developing kidneys, suggesting that both mediators, interacting with their respective receptors at the angioblast surface, are critically important for this process. Invasion of the vascular cleft by angioblasts furthermore may be guided by neuropilin, the receptor for semaphorin III which also binds the 165 kD isoform of VEGF-A [8] . A role for podocyte ephrin-B2 in guiding angioblasts into the vascular clefts of developing nephrons has also been postulated [9] .
LUMEN FORMATION
Angioblasts invading the capillary cleft of developing nephrons at the comma-and S-shaped stages first undergo homotypic aggregation into precapillary cords, generally without a recognizable lumen [7, 10, 11] . Assembly of renal microvascular endothelial cells into precapillary cords through homotypic interactions between cells appears to be regulated by Eph-like kinase (ELK) receptors, as these are expressed by angioblasts in the developing kidney and can induce aggregation of cultured microvascular endothelial cells in response the their ligand LERK-2 [12] . The process of endothelial cell aggregation within the vascular cleft of developing glomeruli is reminiscent of the TGF-b1-dependent migration and aggregation into precapillary cords of glomerular endothelial cells in vitro [13] . Like glomerular precapillary cords, such structures initially are solid cords but develop a lumen after several days in culture. In vivo, glomerular capillary lumen formation in developing rat kidney involves removal of superfluous endothelial cells from the precapillary cord by TGF-b1-induced apoptosis ( Fig. 1 ) [11] . Hence, unlike the process of angiogenesis in which a sprouting vessel containing a lumen invades the tissue being vascularized, glomerular capillaries form through homotypic endothelial cell interaction to form a precapillary cord. The lumen is then shaped as a distinct event requiring apoptosis of a subset of these endothelial cells.
FORMATION OF FENESTRAE
The final steps in glomerular endothelial cell differentiation involve flattening of the cells against the glomerular basement membrane and formation of fenestrae. Fenestrae are plasma membrane-lined circular pores that perforate the flattened glomerular endothelium. Fenestrae in nonglomerular endothelial cells are bridged by a very thin, 5 to 6 nm diaphragm consisting of glycoproteins, that is continuous with the outer leaflet of the plasma membrane, and often contains a central knob [14] . It was long held that glomerular fenestrae lack a diaphragm [15] but recent work suggests that glomerular fenestrae, like peritubular and other fenestrated endothelia, contain a bridging diaphragm [16] . Actin microfilaments, which surround fenestrae, have been postulated to regulate their shape and diameter [17] .
That VEGF regulates fenestrae formation was initially suggested by Breier et al [18] who found that mature fenestrated endothelium is typically located adjacent to epithelial cells expressing VEGF at high levels, and that the highest levels of VEGF mRNA are found in mature glomerular podocytes. VEGF can rapidly induce fenes-trae formation in capillaries of both skin and skeletal muscle in vivo [19] , and tumors secreting VEGF develop a fenestrated neovasculature [20] . In the kidney, the elegant work by Eremina et al [21] showed that podocyte specific deletion of a single VEGF-A allele produces glomeruli in which the glomerular capillary endothelium fails to fully differentiate, in that it does not flatten or fenestrate. The glomerular lesion with this partial deletion of podocyte VEGF-A resembles that found in preeclampsia, as these mice were also noted to have significant proteinuria. Podocyte-specific homozygous deletion of VEGF-A produced a more severe lesion due to lack of endothelial migration and differentiation. In patients with preeclampsia, higher than normal concentrations of soluble VEGFR-1 (sVEGFR-1) (sFlt-1), which inhibits the interaction of VEGF-A with full-length transmembrane VEGFR tyrosine kinases and their activation, are found in plasma and correlate with the severity of the renal lesion [22] . Moreover, in mature mice given neutralizing VEGF antibody or sVEGFR-1, rapid loss of endothelial cell fenestrae, endothelial cell swelling, and proteinuria were observed [23] . Finally, deletion of the podocytespecific transcription factor LMX1B in mice, which results in the loss of many features of podocyte differentiation, including a loss of VEGF-A expression, also results in a glomerular endothelium that remains undifferentiated in that it is thickened and fails to develop fenestrae [24] . Taken together, these studies prove that the final differentiation of glomerular endothelial cells is podocytedependent, and that podocyte-derived VEGF-A is a necessary mediator of glomerular endothelial cell differentiation. Also of note, the rapid reversal of endothelial cell fenestration that was observed when VEGF-A action was inhibited in mice [23] suggests that the formation of fenestrae is a very dynamic process.
VEGF-mediated induction of fenestrae in vitro results in fusion of intracellular vesicles [25] , also known as vesiculovacuolar organelles (VVO). VVOs contain caveolin-1 and are thought to represent precursors of caveolae and fenestrae [26] . The protein PV-1, initially isolated from the apical plasma membrane of pulmonary endothelium, is specifically associated with the bridging diaphragms of endothelial fenestrae and caveolae [27] . Induction of VVO fusion, furthermore, is PV-1-dependent [28] . Because fenestral and caveolar diaphragms contain PV-1, and because fusion of PV-1 and caveolin-1 containing VVOs is induced by VEGF and associated with the formation of transendothelial cell channels, it has been argued that endothelial cell fenestrae represent fused caveolae, and that VEGF induces their fusion. However, Esser et al [25] noted that caveolin-1 is absent from fenestrae of cultured endothelial cells and from fenestrae of choroid plexus endothelium in vivo. It is also of note that PV-1 is uniquely absent from glomerular endothelial cell fenestrae [26] despite the fact that fenestral diaphragms are found in glomerular endothelial cell fenestrae [29]. To determine whether glomerular endothelial cell fenestrae represent fused caveoli, we examined human glomeruli by immunogold electron microscopy, and found that the fenestrated region of glomerular endothelium is completely devoid of caveolin-1. Furthermore, caveolin-1-deficient mice, which do not form caveolae, nevertheless had a fully differentiated glomerular endothelium with a fenestrae density similar to that of wild-type controls [30] . The lack of PV-1 and caveolin-1 in glomerular fenestrae, and the finding that caveolin-1-deficient mice make perfectly normal glomerular fenestrae suggest strongly that fenestrae in glomerular endothelial cells differ at the molecular level from those in other vascular beds, and that they do not represent fused caveolae.
CONCLUSION
The molecular mechanisms of glomerular endothelial cell development and differentiation are increasingly well understood. Steps in their development and differentiation represent a unique set of interactions between podocytes and the endothelial cells.
